Skip to main content
Log in

Detection of late onset steroid 21-hydroxylase deficiency by capillary gas chromatographic profiling of urinary steroids in children and adolescents

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Patients suffering from late onset 21-hydroxylase deficiency (LO-CAH) excreted only slightly higher amounts of 17-hydroxypregnanolone (17-OH-PO), pregnanetriol (PT) and 11-oxo-pregnanetriol (11-O-PT) than age-matched healthy controls. To discriminate between LO-CAH and virilization of unknown origin and precocious pubarche, we calculated the following ratios: (1) pregnanetriol to tetrahydrocortisone (PT/THE), (2) the sum of 17-OH-PO, PT and 11-O-PT (OHP-M) to the sum of THE, tetrahydrocortisol (THF) and allotetrahydrocortisol (a-THF) (C-M) and (3) 11-O-PT to C-M. The following patients were studied: 9 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency-non-salt losing (CAH-NSL), never treated; 8 patients with CAH (NSL/SL: 3/5) off treatment; 10 patients with LO-CAH; 11 patients with virilization of unknown origin (prepubertal/pubertal: 5/6) and 9 patients with precocious pubarche. Healthy individuals and obligatory heterozygote carriers of comparable ages served as controls. LO-CAH showed increased ratios (median (range)) of PT/THE: 2.27, (1.15–9.09), OHP-M/C-M: 2.30, (1.24–8.15), and 11-O-PT/C-M: 0.24, (0.13–1.23) compared to healthy individuals and heterozygous carriers: PT/THE 0.28, (0.03–0.57), OHP-M/C-M 0.23, (0.06–0.46) and 11-O-PT/C-M<0.01, (<0.01–0.06), respectively. The calculation of ratios, rather than absolute amounts seems to allow the detection of LO-CAH in a single spontaneously voided urine specimen. The clinical and measurable hormonal manifestations of LO-CAH occur at the same time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

LO-CAH:

late onset 21-hydroxylase deficiency

CAH:

congenital adrenal hyperplasia due to 21-hydroxylase deficiency

SL:

salt losing

NSL:

non-salt losing

p.p.:

prepubertal

p.:

pubertal

17-OH-PO:

17-hydroxypregnanolone (5β-pregnane-3α,17α-diol-20-one)

PT:

pregnanetriol (5β-pregnane-3α,17α,20α-triol)

11-O-PT:

11-oxo-pregnanetriol (5β-pregnane-3α,17α,20α-triol-11-one)

THE:

tetrahydrocortisone (5β-pregnane-3α,17α,21-triol-11,20-dione)

THF:

tetrahydrocortisol (5β-pregnane-3α,11β,17α,21-tetrol-20-one)

a-THF:

allotetrahydrocortisol (5α-pregnane-3α,11β,17α,21-tetrol-20-one)

OHP-M:

17-OH-PO+PT+11-O-PT

C-M:

THE+THF+a-THF

References

  1. Andler W, Malvaux P, Zachmann M, Prader A (1974) Kongenitales adrenogenitales Syndrom mit ungewöhnlich leichtem 21-Hydroxylase-Defekt. Monatsschr Kinderheilkd 122:619

    Google Scholar 

  2. Auchterlonie IA, Cameron J, Wallace AM, Rudd BT, Hudson M, Smail PJ (1985) Prepubertal gynaecomastia as the presenting feature of late-onset 21-hydroxylase deficiency. Horm Res 22: 94–99

    Google Scholar 

  3. Chrousos GP, Loriaux DL, Mann D, Cutler GB Jr (1982) Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations. Horm Res 16: 193–200

    Google Scholar 

  4. Decourt MJ, Jayle MF, Baulieu E (1957) Virilisme cliniquement tardif avec excrétion de pregnanetriol et insuffisance de la production du cortisol. Ann Endocrinol (Paris) 18:416–426

    Google Scholar 

  5. Dewailly D, Vantyghem-Haudiquet M-C, Sainsard C, Buvat J, Cappoen JP, Ardaens K, Racadot A, Lefebvre J, Fossati P (1986) Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab 63:418–423

    Google Scholar 

  6. Dupont B, Oberfield SE, Smithwick EM, Lee TD, Levine LS (1977) Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet II:1309–1311

    Google Scholar 

  7. Gleispach H (1973) Die Ausscheidung von 17-Oxosteroiden, Pregnanen und von Testosteron im menschlichen Harn in Abhängigkeit von Alter und Geschlecht. Z Klin Chem Klin Biochem 11: 482–486

    Google Scholar 

  8. Gleispach H, Glatzl J, Rössler H (1969) Biochemische Spätmanifestation eines congenitalen Adrenogenitalsyndroms bei einem Mädchen. Pädiatr Pädol 5:307–315

    Google Scholar 

  9. Gleispach H, Berger H, Glatzl J, Rössler H, Tschager E (1971) Pregnantriolon-Ausscheidung nach ACTH-Stimulierung bei mutmaßlichen heterozygoten Merkmalsträgern eines 21-Hydroxylasedefektes. Pädiatr Pädol 6:287–296

    Google Scholar 

  10. Gleispach H, Auer B, Frisch H, Karpellus P (1974) Ein Beitrag zur Ausscheidung von Cortisol, Tetrahydrocortisol und Tetrahydrocortison im Harn von Knaben. Pädiatr Pädol 9:80–83

    Google Scholar 

  11. Gourmelen M, Pham-Huu-Trung MT, Bredon MG, Girard F (1979) 17-Hydroprogesterone in the cosyntropin test: Results in normal and hirsute women and in mild congenital adrenal hyperplasia. Acta Endocrinol (Copenh) 90:481–489

    Google Scholar 

  12. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of hand and wrist, 2nd edn. Stanford University Press, Stanford, Calif.

    Google Scholar 

  13. Grosse-Wilde H, Weil J, Albert E, Scholz S, Bidlingmaier F, Sippel WG, Knorr D (1979) Genetic linkage studies between congenital adrenal hyperplasia and the HLA blood group system. Immunogenetics 8:41–49

    Google Scholar 

  14. Holsboer F, Knorr D (1977) Determination of urinary 17-hydroxypregnanolone by gas chromatography-mass spectrometry in patients with congenital adrenal hyperplasia. J Steroid Biochem 8:1197–1199

    Google Scholar 

  15. Kecskés L, Tényi I, Németh M, Juricskay Zs, Temesi M (1975) Significance of 3α,17α-dihydroxy-5β-pregnane-20-one in the diagnosis of congenital adrenal hyperplasia. Endokrinologie 66:94–99

    Google Scholar 

  16. Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner AJ, Rondanini GF, Dupont B, New MI (1982) Late-onset steroid 21-hydroxylase deficiency: A variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 55:817–827

    Google Scholar 

  17. Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucekkine C, Thalabard J-C, Maudelonde T, Spritzer P, Mowszowicz I, Boue A, Mauvais-Jarvais P (1985) Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313:224–231

    Google Scholar 

  18. Lee PA, Rosenwaks Z, Urban MD, Migeon CJ, Bias WD (1982) Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 55:866–871

    Google Scholar 

  19. Levine LS, Zachmann M, New MI, Prader A, Pollack MS, O'Neill GJ, Yang SY, Oberfield SE, Dupont B (1978) Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. N Engl J Med 299:911–915

    Google Scholar 

  20. Lorenzen F, Pang S, New M, Pollack M, Oberfield S, Dupont B, Chow D, Schneider B, Levine L (1980) Studies of the C-21 and C-19 steroids and HLA genotyping in siblings and parents of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 50:572–577

    Google Scholar 

  21. Migeon CJ, Rosenwaks Z, Lee PA, Urban MD, Bias WB (1980) The attenuated form of congenital adrenal hyperplasia as an allelic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 51:647–649

    Google Scholar 

  22. Milewicz A, Vecsei P, Korth-Schütz S, Haack D, Rösler A, Lichtwald K, Lewicka S, v. Mittelstaedt G (1984) Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency. J Steroid Biochem 21:185–191

    Google Scholar 

  23. New MI, Lorenzen F, Pang S, Gunczler P, Dupont B, Levine LS (1979) “Acquired” adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorder as congenital adrenal hyperplasia. J Clin Endocrinol Metab 48:356–359

    Google Scholar 

  24. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS (1983) Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data. J Clin Endocrinol Metab 57:320–326

    Google Scholar 

  25. Petersen KE, Svejgaard A, Damkjær Nielsen M, Dissing J (1982) Heterozygotes and cryptic patients in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency). HLA and glyoxylase I typing and hormonal studies. Horm Res 16:151–159

    Google Scholar 

  26. Pfeifer P, Spiteller G (1981) Steroid profiles of healthy individuals. J Chromatogr 223:21–32

    Google Scholar 

  27. Pollack MS, Levine LS, O'Neill GJ, Pang S, Lorenzen F, Kohn B, Rondanini GF, Chiumello G, New MI, Dupont B (1981) HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency. Am J Hum Genet 33:540–550

    Google Scholar 

  28. Rosenwaks Z, Lee PA, Jones GS, Migeon CJ, Wentz AC (1979) An attenuated form of congenital virilising adrenal hyperplasia. J Clin Endocrinol Metab 49:335–339

    Google Scholar 

  29. Shackleton CHL (1985) Mass spectrometry: Application to steroid and peptide research. Endocr Rev 6:441–486

    Google Scholar 

  30. Shackleton CHL (1986) Review. Profiling steroid hormones and urinary steroids. J Chromatogr 379:91–156

    Google Scholar 

  31. Shackleton CHL, Honour JW (1976) Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neonatal infants and children with abnormal steroid synthesis. Clin Chim Acta 69:267–283

    Google Scholar 

  32. Shackleton CHL, Whitney JO (1980) Use of Sep-Pak® cartridges for urinary steroid extraction: Evulation of the method for use prior to gas chromatographic analysis. Clin Chim Acta 107:231–243

    Google Scholar 

  33. Shackleton CHL, Taylor NF, Honour JW (1980) An atlas of gas chromatographic profiles of neutral urinary steroids in health and disease. Packard, Delft Zürich Downers Grove, Ill., pp 40–41

    Google Scholar 

  34. Solyom J, Hammond GL, Vihko R (1979) A method for identification and follow-up of patients with a steroid-21-hydroxylase deficiency. Clin Chim Acta 92:117–124

    Google Scholar 

  35. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650–667

    Google Scholar 

  36. Staib W, Teller W (1959) Über die postpuberale Form des adrenogenitalen Syndroms. Klin Wochenschr 37:979–986

    Google Scholar 

  37. Vierhapper H, Nowotny P, Waldhäusl W, Frisch H (1985) Capillary gas chromatography as a tool for characterization of urinary steroid excretion in patients with congenital adrenal hyperplasia. J Steroid Biochem 22:363–369

    Google Scholar 

  38. Viinikka L, Jänne O, Perheentupa J, Vihko R (1973) Congenital adrenal hyperplasia. Plasma and urinary steroid conjugates in seven children with steroid 21-hydroxylase deficiency. Clin Chim Acta 48:359–365

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Enno Kleihauer, Ulm, on the occasion of his 60th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Homoki, J., Solyom, J. & Teller, W.M. Detection of late onset steroid 21-hydroxylase deficiency by capillary gas chromatographic profiling of urinary steroids in children and adolescents. Eur J Pediatr 147, 257–262 (1988). https://doi.org/10.1007/BF00442691

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442691

Key words

Navigation